In provoked VTE with ≥1 enduring risk factor, extending anticoagulation with apixaban reduced symptomatic recurrent VTE at 12 mo

ACP Journal Club Editorial Team at McMaster University

doi:10.7326/ANNALS-25-04963-JC

In provoked VTE with ≥1 enduring risk factor, extending anticoagulation with apixaban reduced symptomatic recurrent VTE at 12 mo

ACP Journal Club Editorial Team at McMaster University

Research output: Contribution to journal › Article › peer-review

Abstract

CLINICAL IMPACT RATINGS: GIM/FP/GP: [Formula: see text] Hematology: [Formula: see text].

Original language	English
Pages (from-to)	JC10
Journal	Annals of Internal Medicine
Volume	179
Issue number	1
DOIs	https://doi.org/10.7326/ANNALS-25-04963-JC
State	Published - 1 Jan 2026
Externally published	Yes

Access to Document

10.7326/ANNALS-25-04963-JC

Cite this

@article{862a4e6368dd4b3e8c9f24d68782609c,

title = "In provoked VTE with ≥1 enduring risk factor, extending anticoagulation with apixaban reduced symptomatic recurrent VTE at 12 mo",

abstract = "CLINICAL IMPACT RATINGS: GIM/FP/GP: [Formula: see text] Hematology: [Formula: see text].",

author = "\{ACP Journal Club Editorial Team at McMaster University\} and Andrew Dunn",

year = "2026",

month = jan,

day = "1",

doi = "10.7326/ANNALS-25-04963-JC",

language = "English",

volume = "179",

pages = "JC10",

journal = "Annals of Internal Medicine",

issn = "0003-4819",

publisher = "American College of Physicians",

number = "1",

}

TY - JOUR

T1 - In provoked VTE with ≥1 enduring risk factor, extending anticoagulation with apixaban reduced symptomatic recurrent VTE at 12 mo

AU - ACP Journal Club Editorial Team at McMaster University

AU - Dunn, Andrew

PY - 2026/1/1

Y1 - 2026/1/1

N2 - CLINICAL IMPACT RATINGS: GIM/FP/GP: [Formula: see text] Hematology: [Formula: see text].

AB - CLINICAL IMPACT RATINGS: GIM/FP/GP: [Formula: see text] Hematology: [Formula: see text].

UR - https://www.scopus.com/pages/publications/105027928994

U2 - 10.7326/ANNALS-25-04963-JC

DO - 10.7326/ANNALS-25-04963-JC

M3 - Article

C2 - 41490499

AN - SCOPUS:105027928994

SN - 0003-4819

VL - 179

SP - JC10

JO - Annals of Internal Medicine

JF - Annals of Internal Medicine

IS - 1

ER -

In provoked VTE with ≥1 enduring risk factor, extending anticoagulation with apixaban reduced symptomatic recurrent VTE at 12 mo

Abstract

Access to Document

Fingerprint

Cite this